Key Insights

Highlights

Success Rate

79% trial completion

Published Results

20 trials with published results (13%)

Research Maturity

67 completed trials (43% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.6%

18 terminated out of 155 trials

Success Rate

78.8%

-7.7% vs benchmark

Late-Stage Pipeline

10%

15 trials in Phase 3/4

Results Transparency

30%

20 of 67 completed with results

Key Signals

20 with results79% success18 terminated

Data Visualizations

Phase Distribution

117Total
Not Applicable (45)
Early P 1 (2)
P 1 (29)
P 2 (26)
P 3 (10)
P 4 (5)

Trial Status

Completed67
Unknown40
Terminated18
Recruiting16
Not Yet Recruiting5
Active Not Recruiting5

Trial Success Rate

78.8%

Benchmark: 86.5%

Based on 67 completed trials

Clinical Trials (155)

Showing 20 of 20 trials
NCT06486454RecruitingPrimary

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

NCT07556835Not Yet RecruitingPrimary

Outcomes After Liver and Biliary Resection at a High-Volume Center

NCT07377487Not ApplicableRecruitingPrimary

TheraSphere Japan Pre-Market Study

NCT07227012Phase 1Recruiting

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

NCT07192172Not ApplicableCompleted

Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes

NCT06687941Phase 1Recruiting

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

NCT04008797Phase 1Active Not Recruiting

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

NCT07473687Recruiting

Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room

NCT04075305Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

NCT07407257Not ApplicableCompletedPrimary

SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors

NCT07414433Not Yet Recruiting

Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

NCT06261814Phase 2RecruitingPrimary

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

NCT03715517Not ApplicableRecruiting

Spinal Anesthesia For Enhanced Recovery After Liver Surgery

NCT07378709Recruiting

Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

NCT07346573CompletedPrimary

Radiotherapy Safety for Liver Malignancies Using Post-Treatment Imaging

NCT04573881Not ApplicableActive Not RecruitingPrimary

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

NCT07225114Phase 2Recruiting

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

NCT04618692Not ApplicableCompleted

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

NCT07246668Phase 2Recruiting

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

NCT07243951Phase 2Not Yet Recruiting

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Scroll to load more

Research Network

Activity Timeline